USFDA okays Lenacapavir: Affordable, generic India-made drug key to boost global HIV prevention
New Delhi, June 21 (IANS) While Gilead Sciences’ HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made-in-India generic versions may be a more affordable alternative that can boost the prevention of the deadly condition globally.